Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

By B. Duncan, M. Schmidt, J. Pankow, Christie M. Ballantyne, D. Couper, Á. Vigo, R. Hoogeveen, A. Folsom, G. Heiss. Diabetes, 2003

1,049 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Brain-derived neurotrophic factor (BDNF) and type 2 diabetes (2007, background): “Systemic low-grade inflammation is defined as two to fourfold increases in circulating levels of inflammatory markers such as CRP [31], and many reports confirm an association between low-grade systemic inflammation on the one hand, and the metabolic syndrome, type 2 diabetes and atherosclerosis on ”
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. (2014, background): “and PAI-1 [15,18] as predictors of T2DM.”
Inflammatory markers and risk of developing type 2 diabetes in women. (2004, background): “A recent study suggested a significant association between inflammation and diabetes among nonsmokers but not smokers (28).”